CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT-HF study The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced

Expert Opinion2020 Oct 14;41(39):3769-3773.

JOURNAL:Eur Heart J. Article Link

The multiple causes and treatments of heart failure: focus on genetic and molecular mechanisms and non-pharmacological interventions

F Crea. Keywords: HF; non-pharmacological interventions; mechanisms

Full Text PDF